Seen it plenty of times, they file a 144 and don't sell. If he sold all 2 mill shares it would take the stock down to $2. I think it would make the VCs very mad lol
He holds MLNM also. We can check to see when he filed to sell with them also.
I believe MNTA and MLNM have the same business plan.
bellwetherreport.com: Bellwether Report.com Looks Under the Microscope at Momenta Pharmaceuticals Inc.
Thursday , August 17, 2006 11:09 ET
Aug 17, 2006 (M2 PRESSWIRE via COMTEX) -- The Bellwether Report Takes Notice of Momenta Pharmaceuticals Inc. (Nasdaq:MNTA)
Momenta Pharmaceuticals increases momentum for good drugs. The biotech company specializes in ordering and engineering complex sugars to improve versions of existing drugs, as well as to discover more-effective new drugs. By analyzing and sequencing complex sugars, the company provides a more comprehensive picture of the roles sugars play in cell function, disease, and drug action. Momenta has several products in the pipeline, including M-Enoxaparin, a generic version of heparin drug Lovenox from Sanofi-Aventis. The drug candidate could be used to treat patients with deep-vein thrombosis and acute coronary syndromes. Candidate M-Dalteparin is a generic version of Pfizer's Fragmin heparin product.
Shares were up 2% after announcing Presentation at the Bank of America 2006 Specialty Pharmaceuticals Conference.
Momenta Pharmaceuticals, Inc. a biotechnology company developing drugs based on its proprietary sugar sequencing technology, announced that Richard P. Shea, Vice President, Chief Financial Officer, will present at the Bank of America 2006 Specialty Pharmaceuticals Conference on Friday August 11, 2006 at 10:30 am EDT at Southampton Inn, Southampton, NY.
A live audio webcast of the presentation will be available on.....
To review research on Momenta Pharmaceuticals Inc. as well as many more exciting articles we encourage you to visit www.bellwetherreport.com. You can find these reports under the "Today's Articles" section. No credit Card Needed!!
The Bellwether Report will continue to research the small cap markets to bring you exciting opportunities!! If you are interested in receiving more information on these small cap opportunities and other features of our site, feel free to sign up for a complimentary subscription to the #1 online investment tool www.bellwetherreport.com.
Companies looking to advertise with Bellwether Report should email jlee@bellwetherreport.com with the subject line (Advertising).
All material herein was prepared by the Bellwetherreport.com, (Bellwether) based upon information believed to be reliable. The information contained herein is not guaranteed by Bellwether to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Bellwether is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Bellwether may receive compensation in cash or shares from independent third parties or from the companies mentioned.
Bellwether's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value.
Bellwether will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Bellwether undertakes no obligation to update such statements.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
As of Sunday, 08-13-2006 23:59, the latest Comtex SmarTrend(SM) Alert, an automated pattern recognition system, indicated an UPTREND on 07-25-2006 for MNTA @ $16.80.
For more information on Comtex SmarTrend® Alert, contact your market data provider or go to CSTADirect.com
Market Data 
Markets 
AI
